Matthew Smith
Pulmonary Disease · Largo, FLNPI 1588688543
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 380 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by GSK at 28.2% of the total. Reporting peaked in 2019 at $2,526 and has fallen 56.2% since, to $1,107 in 2022.
Across 380 payments — averaging $16.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- AstraZeneca$1K
- Boehringer Ingelheim$685
- Mylan Specialty L.p.$554
- Sunovion Pharmaceuticals Inc.$286
- Jazz Pharmaceuticals Inc.$225
- plus $1K from 17 others
What the payments were for
- Food & beverage$6,344100%
- Education$290%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 155 | $1,796 |
| AstraZeneca | 64 | $1,482 |
| Boehringer Ingelheim | 37 | $685 |
| Mylan Specialty L.p. | 37 | $554 |
| Sunovion Pharmaceuticals Inc. | 12 | $286 |
| Jazz Pharmaceuticals Inc. | 6 | $225 |
| Regeneron Healthcare Solutions, Inc. | 15 | $211 |
| Teva Pharmaceuticals USA, Inc. | 10 | $204 |
| United Therapeutics Corporation | 3 | $138 |
| Genentech USA, Inc. | 7 | $112 |
| Novartis | 5 | $97 |
| Amgen | 4 | $86 |
| Harmony Biosciences LLC | 3 | $65 |
| Vapotherm Inc | 3 | $65 |
| Bayer | 3 | $65 |
| Sanofi | 3 | $59 |
| Insmed, Inc. | 3 | $58 |
| Covis Pharma GmbH | 2 | $49 |
| Eisai Inc. | 3 | $45 |
| Baxter Healthcare | 2 | $44 |
| Inogen, Inc. | 1 | $23 |
| Nabriva Therapeutics, PLC | 1 | $13 |
| Circassia Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$354
- BREZTRI$125
- SUNOSI$125
- TEZSPIRE$101
- ANORO$101
How this compares
$6,373 in reported general payments places this provider in the 65th percentile of 953 pulmonary disease providers in Florida.
Other pulmonary disease in Largo
- Franck RahaghiWeston$1.2M
- Michael OttEglin Afb$909K
- Ali JiwaniOrlando$859K
- Anas HadehWeston$800K
- Jennifer FultonJacksonville$665K
- Ricardo Restrepo-JaramilloTampa$555K
- Mark RumbakTampa$528K
- Jose Soto SotoJacksonville$504K
- Javier Perez FernandezMiami$496K
- Domenick ReinaTampa$469K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.